Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
After analyzing data from 228,000 people in Sweden, researchers wrote in a November 2024 study in JAMA Psychiatry that people on a GLP-1 medication had a lower risk of being hospitalized for alcohol-related issues, concluding that they offer promise as a novel treatment to reduce alcohol consumption and to prevent development of alcohol-related outcomes. Again, research on this is developing in real time, so docs arent quite sure whats behind this effect
Transfer of nanocarriers across the BBB and biological effects The main goals for BBB-targeted nanocarriers are at least three-fold, namely increase solubility, enhance brain penetration to reach better therapeutic efficiency, and minimize peripheral side-effects
Clinica Chimica Acta 412, 797801 (2011)
There are also prescribing limits, Rothberg says
10.1016/j.phrs.2012.10.015 Pharmacol
